Seeking Alpha

GlaxoSmithKline (GSK) has fired the head of its Chinese R&D unit, Jingwu Zhang, following an...

GlaxoSmithKline (GSK) has fired the head of its Chinese R&D unit, Jingwu Zhang, following an investigation into allegations of data fabrication in a 2010 scientific paper on multiple sclerosis (MS) that was published in Nature Medicine. Another scientist has resigned, while GSK has put another three on "administrative leave" pending a final review. SA author Derek Lowe has lots of questions, including "how many more things have been faked as well?" (PR)
Comments (2)
  • Sesame Stock Picker
    , contributor
    Comments (69) | Send Message
     
    Remember Avandia?
    11 Jun 2013, 11:08 AM Reply Like
  • pharmaed
    , contributor
    Comments (2) | Send Message
     
    why not link to Pharmalot, which was the first to report the R&D chief was dismissed?

     

    http://bit.ly/19r8ExU
    12 Jun 2013, 02:41 PM Reply Like
DJIA (DIA) S&P 500 (SPY)